Using meditation and biofeedback to help stroke patients with anxiety and depression
Using a Technology-based Meditation Program Administered Through the iom2 Biofeedback Device to Reduce Depression and Anxiety and Improve QOL in the Inpatient Stroke Rehabilitation Setting
NA · Sunnybrook Health Sciences Centre · NCT05845541
This study is testing if a meditation program using technology can help stroke patients feel less anxious and depressed while improving their overall quality of life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sunnybrook Health Sciences Centre (other) |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT05845541 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of a technology-based meditation program on inpatients who have experienced a stroke within the last two months. The study aims to determine if this approach can effectively reduce symptoms of anxiety and depression while improving the overall quality of life for these patients. Participants will engage in meditation therapy at least three times a week and complete surveys to assess their mental health and quality of life before discharge. The trial emphasizes patient-centered care and aims to provide holistic support for stroke survivors.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are in inpatient rehabilitation after experiencing a stroke within the past two months and are at risk for depression or anxiety.
Not a fit: Patients with significant comorbid psychiatric or neurological disorders, or those unable to provide informed consent, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the mental well-being and quality of life for stroke survivors.
How similar studies have performed: Other studies have shown promising results using similar meditation and biofeedback approaches for mental health improvement, suggesting potential success for this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (18 years and older) * Inpatient rehabilitation patients at St. John's Rehab * Experienced a stroke within the past two months prior to study enrollment * Identified as being at risk for depression and/or anxiety based on their scores on study screening tools * Able to comply with study requirements Exclusion Criteria: * Younger than 18 years old * Significant comorbidity including psychiatric or neurological disorder (not including premorbid depression or anxiety) * Inability to complete any of the outcome measures * Starting a new antidepressant or a change in antidepressant medication within the past 6 months * Inability to provide informed consent * For qualitative interviews, patients can have experienced a stroke within one year. * For focus groups, staff who work significantly with stroke patients at St. John's Rehab. Staff can be physicians, nurses, allied health.
Where this trial is running
Toronto, Ontario
- St. John's Rehab — Toronto, Ontario, Canada (RECRUITING)
Study contacts
- Principal investigator: Amanda Ratner, M.Sc. — Sunnybrook Health Sciences Centre
- Study coordinator: Amanda Ratner, M.H.Sc.
- Email: amanda.ratner@sunnybrook.ca
- Phone: 416-226-6780
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke, Meditation, Biofeedback, Depression, Anxiety, Inpatient